ORBIMED ADVISORS LLC Monte Rosa Therapeutics, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$960,000
portfolio value

Monte Rosa Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 117.45K shares 960K $8.17 117.45K
Q3 2021 share Decrease -100.00% -350K shares -7.94M $22.28 0
Q2 2021 share Increase 0.00% 350K shares 7.94M $22.7 350K